125
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

, , , , , , , , & show all
Pages 31-37 | Published online: 09 Feb 2018

Figures & data

Figure 1 Rates of hypofractionation and RT omission for the years 2006–2008 and 2011–2013. WBRT hypofractionation rates are for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer. RT omission rates are for patients aged >70 years. Rates at our NCCN-member institution are compared to national rates per Bekelman et alCitation24 and Palta et al.Citation25P<0.001 for statistical difference between the 2006–2008 and 2011–2013 institution-specific hypofractionation rates. P=0.11 for statistical difference between the 2006–2008 and 2011–2013 institution-specific RT omission rates.

Abbreviations: NCCN, National Comprehensive Center Network; RT, radiotherapy; WBRT, whole-breast radiotherapy.
Figure 1 Rates of hypofractionation and RT omission for the years 2006–2008 and 2011–2013. WBRT hypofractionation rates are for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer. RT omission rates are for patients aged >70 years. Rates at our NCCN-member institution are compared to national rates per Bekelman et alCitation24 and Palta et al.Citation25P<0.001 for statistical difference between the 2006–2008 and 2011–2013 institution-specific hypofractionation rates. P=0.11 for statistical difference between the 2006–2008 and 2011–2013 institution-specific RT omission rates.

Table 1 RT practice patterns for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer at our NCCN-member institution

Table 2 Direct medical cost for whole-breast radiotherapy